Clinical Trial

Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 31, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this study, 18F-Florastamin PET/CT will be performed in patients with suspected recurrence of prostate cancer, to assess the diagnostic performance and safety of 18F-Florastamin PET/CT imaging.
Trial Details
NCT Number NCT06754085
Lead Sponsor HTA Co., Ltd.
Conditions Prostate Cancer
Enrollment 131 participants
Start Date 2024-12-19
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-31